Oncogenic YAP accelerates S-phase entry by shortening G1, leading to replication stress and sensitivity to CHK1 inhibition.

D Molecular Therapeutics said it is streamlining operations to offset expected expenses as it accelerates the timelines for its Phase III trials.

Researchers successfully developed a nanomaterial capable of simultaneously performing cancer diagnosis, treatment, and ...

A recent review by Prof. Zhu Bing and Associate Professor Xiong Jun from the Institute of Biophysics of the Chinese Academy ...

Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

Melanin can either protect or worsen hereditary hearing loss depending on genetic context, as reported by researchers from ...

Researchers have uncovered how losing the autism-linked gene PTEN in a specific set of inhibitory neurons reshapes brain circuits tied to fear and anxiety.

The study provides a potential framework for dissecting mechanisms underpinning the failure of regeneration in other organs ...

In a bold move to redefine the future of human performance and wellbeing, MAXIOM Labs and DNAthlete AG today announced a strategic partnership to combine ...

Investigating how mutations in tumors alter DNA’s 3D structure—and subsequently, regulatory sequences called enhancers—can ...